Glassman Wealth Services’s NanoViricides NNVC Stock Holding History

Glassman Wealth Services’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	1897
2022 Q1	$0	Buy	+1	New	+$2	﹤0.01%	1848

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Glassman Wealth Services's NNVC Position: Q2 2022 in Review

Glassman Wealth Services sold out of NanoViricides (NNVC) in Q2 2022, closing a stake of 1 share.

Glassman Wealth Services first reported a position in NNVC in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 25 funds tracked by Wall St. Rank hold NNVC as of Q2 2022.

Glassman Wealth Services reported no remaining NanoViricides position as of Q2 2022 after selling out during the quarter.
Glassman Wealth Services sold 1 NanoViricides share in Q2 2022.
Glassman Wealth Services first reported a position in NanoViricides in Q1 2022 and held it in 1 quarter.
Glassman Wealth Services's NanoViricides position peaked at $0 in Q1 2022.
25 funds tracked by Wall St. Rank held NanoViricides as of Q2 2022.

Based on Glassman Wealth Services's 13F filing for Q2 2022, filed 4 Aug 2022.